Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
NCT04362644
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG:
PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
Sponsor
University of Alabama at Birmingham